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Abstract
Pre-gestational diabetes is often compounded by hypertensive 
disease of pregnancy. In this study, women diagnosed as 
suffering from pre-gestational diabetes mellitus (pre-DM) were 
subdivided into two groups: those found to be suffering from 
some form of hypertension during their pregnancy (n=18); and 
those who did not develop hypertension (n=75). The maternal 
characteristics and perinatal outcome of the two groups were 
statistically correlated. The results showed that type of diabetes 
was the only statistically significant correlate to the likelihood 
to develop hypertension. The infant was more likely to have a 
higher mean birth weight in pre-DM women with hypertension 
than those without. Perinatal morbidity and mortality did not 
show any significant differences.
Introduction
Women with pre-gestational diabetes have been shown to 
have a significantly higher risk of having a pregnancy complicated 
by hypertensive disease of mixed aetiology when compared to 
women with normal carbohydrate metabolism.1 This observation 
is not at all surprising since pre-gestational diabetes has been 
shown to be a harbinger of later onset vascular disease. The 
appearance of hypertensive disease should further compound 
the clinical situation with increased stress being placed on the 
mother and the placento-fetal unit giving rise to increased 
maternal and fetal morbidity or mortality. The present study 
attempts to quantify the clinical effect of hypertensive disease 
on pre-gestational diabetes mellitus (pre-DM) pregnancies.
Materials and methods
Women attending the Obstetric Diabetic Clinic at the 
National Hospital in Malta during the period over a six-year 
period who were confirmed as suffering from pre-DM including 
T1DM and T2DM/IGT were subdivided into two groups. The 
first group was composed of 18 pre-DM individuals who during 
pregnancy were found to suffer from hypertension as defined by 
the WHO criteria; the second group was composed of 75 pre-
DM individuals whose blood pressure remained persistently 
in the normal range. Cases of multiple births in pre-DM 
women were excluded from the study. The patients’ clinical 
data were reviewed to identify a number of maternal biological 
characteristics (age, pre-pregnancy BMI, parity, history of 
miscarriage, diabetes type), antenatal obstetric problems 
(2nd–3rd trimester haemorrhage not due to placenta praevia), 
intrapartum problems (onset of labour, type of delivery), and 
infant outcome parameters (birth weight, gestation at delivery, 
conditions causing neonatal morbidity, and perinatal mortality). 
The clinical details of the 18 pre-DM pregnancies complicated 
by hypertension were further analysed. The two groups were 
analysed using the student t test and the Fisher and Yates chi 
square test as appropriate. A probability value of <0.05 was 
taken to signify statistical significance. Ethical approval was 
obtained from the appropriate ethics board.
Results
The only statistically significant factor that appeared to 
increase the risk for developing hypertension during pregnancy 
was the existing type of diabetes (p=0.04). Thus women 
suffering from type 2 diabetes or impaired glucose tolerance 
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Table 1: Maternal characteristics and complications
Maternal characteristics 
and complications
Hypertensive
N = 18
Non-hypertensive
N = 75 p value
Maternal age in years (mean ± sd) 30.89 ± 5.38 29.40 ± 5.73 0.32
≤35 years
>35 years
14
4
77.8%
22.2%
65
10
86.7%
13.3%
0.27
Maternal BMI (mean ± sd) 30.23 ± 3.89 28.46 ± 5.97 0.24
Parity
0
1-2
3+
10
7
1
55.6%
38.9%
5.5%
38
32
5
50.7%
42.7%
6.7% 0.43
Miscarriages
0
1
2+
13
3
2
72.2%
16.7%
11.1%
58
11
6
77.3%
14.7%
8.0% 0.43
2nd–3rd trimester haemorrhage not 
due to placenta praevia 0 - 0 -
Type of diabetic condition
T1DM (IDDM)
IGT/T2DM (NIDDM)
9
9
50.0%
50.0%
58
17
77.3%
22.7% 0.04
Planned delivery by
Induction
Elective LSCS
4
6
22.2%
33.3%
25
31
33.3%
41.3% 0.19
Caesarean section delivery 13 72.2% 50 66.7% 0.62
had a 2.6-fold greater predisposition to develop hypertension 
(34.6%) when compared to women suffering from type 1 diabetes 
(13.4%). Women suffering from pre-DM also appeared to be 
more likely to develop hypertensive disease if they were aged 
more than 35 years, obese, and primiparous or giving a history 
of previous miscarriages. However, none of these characteristics 
showed any statistical significance (Table 1). 
The development of hypertension in pre-gestational women 
was apparently not associated with a higher rate in obstetric 
intervention as evident by planned deliveries through elective 
Caesarean section or induction of labour (55.5% in pre-DM + 
BP vs 74.6% in pre-DM – BP; p=0.28). The Caesarean delivery 
rate appeared to be non-statistically significant higher in those 
pre-DM women with hypertension (72.2% vs 66.7%; p=0.87) 
(Table 1). 
The diastolic blood pressure of those patients with diabetes 
was generally controlled with pharmacological treatment so 
that only two cases had a reading greater than 100 mmHg. 
The majority (12 cases) were complicated by mild proteinuria. 
Only two cases had a significant proteinuria. The latter also had 
uric acid levels above 350 µmol/l. Platelet counts were always 
within normal limits. The mean blood urea in the cases was 4.3 
+ 1.1 mmol/l with only three cases having a maximum values 
greater than 5.5 mmol/l; while the serum creatinine was 69.2 
+ 20.4 μmol/l with only one case having a value greater than 
110 μmol/l (value = 134 μmol/l). 
Infants born to pre-DM women with hypertension appeared 
to be significantly (p=0.02) associated with a tendency towards 
higher mean birth weight (3753.61 + 735.39g) when compared to 
infants born to pre-DM women without hypertension (3304.44 + 
711.83g). The tendency towards larger mean infant birth weights 
was evident in both pre-Type 1 and pre-Type 2 diabetic mothers. 
This relatively higher birth weight appears to be related in part 
to an increase in the macrosomia rate and a decrease in low 
birth weight infants in the hypertensive group (Table 2); and 
to the apparent increase of delivery of premature infants at 34 
weeks gestation or less in the non-hypertensive group. Other 
perinatal outcome parameters were not significantly different 
in both groups (Table 2/Figure 1). 
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Discussion
The prevalence of pre-DM would be expected to be similar 
to that reported in the reproductive age female population. 
The prevalence of previously-diagnosed diabetes mellitus and 
impaired glucose tolerance in the Maltese reproductive age 
female population had been estimated by epidemiological 
studies in the early 1980s to be 0.5%.2 The prevalence of pre-
gestational diabetes had been estimated at 0.35%; a rate similar 
to the one reported in the general non-pregnant population 
especially considering that the relative age distribution tends 
to favour a younger population in the pregnancy group.1,3 The 
Table 2: Infant characteristics and complications
Infant characteristics and 
complications
Hypertensive
n = 18
Non-hypertensive
n = 75 p value
Birth weight in g (mean ± sd)
T1DM
T2DM
3753.61 ± 735.39
3555.56  ± 864.17
3951.67 ± 560.49
3304.44 ± 711.83
3356.71 ± 705.14
3126.12 ± 726.93
0.02
<2500g
2500-3999g
>=4000g
0
12
6
-
66.7%
33.3%
8
51
16
10.7%
68.0%
21.3% 0.22
Prematurity
<=34 weeks
35-36 weeks
1
4
5.6%
22.4%
7
10
9.3%
13.3% 0.43
Apgar score 1-7 at 5 min 1 5.6% 3 4.0% 0.58
Respiratory distress syndrome 4 22.4% 12 16.0% 0.37
Shoulder dystocia 0 - 1 1.3% 0.82
Postnatal seizures 0 - 0 -
Perinatal mortality (all stillbirths) 0 - 3 4.0% 0.52
prevalence of hypertension in the non-pregnant Maltese female 
population of reproductive age in the early 1980s was estimated 
at 5.9%.2 The rate of hypertensive disease in pregnancy was 
during the same period reported as 6.8% 4, a figure that has been 
approximately maintained in the period 2000-2004.5 Maltese 
women with pre-gestational diabetes have been reported as 
having a greater incidence of hypertensive disease reaching a 
rate of about 27.3%.1 
The apparent association between hypertensive disease 
and pre-DM suggests that there might be an inter-relationship 
between these two conditions. The present study has shown that 
about a third (34.6%) of women suffering from type 2 diabetes 
and impaired glucose tolerance develop hypertension during 
their pregnancy. Type 2 DM and IGT form part of the complex 
metabolic syndrome which is associated with the eventual 
development of hypertension; and hence the development of 
gestational hypertension in these women reflects an underlying 
tendency to develop essential hypertension later on in life 
which is brought out by the cardiovascular stresses brought on 
by the pregnancy state. A lesser proportion (13.4%) of Type 1 
DM women develops hypertension during pregnancy; this rate 
however is still much greater than that reported in the non-
diabetic population (5.9%) suggesting the Type 1 DM woman 
in the reproductive age group may have already developed a 
degree of vascular disease. 
Hypertensive diseases of pregnancy are the most common 
serious medical disorders seen by obstetricians.6 These diseases 
Figure 1: Infant birth weight in presence of 
hypertension with standard 5% & 95% centile birth 
weight by gestation values
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constitute a range of disorders with different aetiologies and 
pathology. They are generally classified into clinical categories 
without reference to aetiology. Broadly, they may be sub-divided 
into pre-existing conditions, pre-eclampsia syndrome, and 
gestational hypertension. The latter group includes a mixture 
of patients who either develop pre-eclampsia syndrome without 
proteinuria or have a latent underlying essential hypertension 
possibly with a mild degree of renal impairment which becomes 
evident during pregnancy.7 All the hypertensive disorders have 
long been associated with higher rates of maternal and fetal 
mortality and morbidity;7 however the pre-eclampsia syndrome 
gives a greater contribution towards adverse events. No attempt 
has been made in the present study to differentiate between 
the various categories of hypertension, but the majority appear 
to be either cases of pre-existing or gestational hypertension 
possibly with a degree of diabetic renal involvement. Only 
two cases had significant proteinuria with elevated uric acid 
levels. Since placental insufficiency with its adverse effects on 
fetal development is more likely to occur with pre-eclampsia 
syndrome rather than with gestational hypertension, the 
preponderance of the latter form of hypertension would explain 
why the present study failed to demonstrate any particular 
increase in morbidity. Since the development of hypertension 
reflects a more severe form of diabetes, it is not surprising that 
the mean birth weight of infants born to hypertensive pre-DM 
mothers appeared to have a larger mean birth weight. A similar 
inter-relationship of elevated birth weights with hypertensive 
disease has been observed in gestational diabetes. 8
The present study has failed to demonstrate definite 
statistically significant adverse perinatal outcomes in the 
hypertensive group of patients though higher non-statistiacally 
significant rates were observed for mode of delivery and risks of 
prematurity. The lack of observed statistical significance could 
in part be the result of the small population number included 
in the study, which however included all the pre-gestational 
diabetic patients who delivered in the Maltese islands during 
the period of the study.
Conclusions
Pre-gestational diabetes appears to have a greater risk of 
being complicated with hypertensive disease; an observation 
that is probably related to the known association between 
essential hypertension and type 2 diabetes mellitus outside 
pregnancy. The most likely underlying pathophysiology is the 
development of hypertension which is still latent but which 
exhibits itself in the face of the physiological stresses caused 
by pregnancy and the increased clinical surveillance pregnant 
women undergo. While the perinatal morbidity in hypertensive 
pre-DM women does not appear to be significantly affected when 
compared to non-hypertensive ones, strict antenatal vigilance of 
pre-DM women remains essential since the perinatal morbidity 
is only kept at a low level by timely intervention.
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